EA
ATYR

Emerald Acquisition’s aTyr Pharma ATYR Stock Holding History

Emerald Acquisition’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$339K Buy
7,601
+2,293
+43% +$99.1K ﹤0.01% 2573
2016
Q2 		$206K Buy
+5,308
New +$247K ﹤0.01% 2724

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Emerald Acquisition's ATYR Position: Q3 2016 in Review

Emerald Acquisition increased its aTyr Pharma (ATYR) stake by 43% in Q3 2016, buying an estimated $99.1K and bringing the position to 7,601 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Emerald Acquisition first reported a position in ATYR in Q2 2016 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold ATYR as of Q3 2016.

  • Emerald Acquisition held 7,601 shares of aTyr Pharma worth $339K as of Q3 2016.
  • Emerald Acquisition bought 2,293 aTyr Pharma shares in Q3 2016, an estimated $99.1K.
  • aTyr Pharma made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2573 holding.
  • Emerald Acquisition first reported a position in aTyr Pharma in Q2 2016 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.